Biomea Fusion

$7.20 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Biomea Fusion

Biomea Fusion, Inc. operates as a biopharmaceutical company. The Company focuseS on the discovery, development, and commercialization of irreversible small molecules to treat patients with genetically defined cancers. Biomea Fusion serves customers in the United States.

Stock Analysis

last close $7.1
1-mo return -9.6%
3-mo return -36%
avg daily vol. 169.06T
52-week high 22.22
52-week low 6.89
market cap. $206M
forward pe -
annual div. -
roe -217.9%
ltg forecast -
dividend yield -
annual rev. $--
inst own. 59.2%
baraka

Subscribe now for daily local and international financial news

Subscribe